Wong et al. reported that SLC25A22 (a mitochondrial glutamine transporter) was a synthetic lethal metabolic gene in KRAS-mutant CRC cells and that expression of SLC25A22 was correlated with poor prognosis in patients harboring KRAS mutations [11]. Here, SLC25A22 is linked to colorectal carcinoma.